UV exposure is the single most significant driver of visible skin ageing. Here is why daily SPF is the one skincare step that is genuinely non-negotiable.
Most skincare claims rest on small studies, ingredient lists, or plausible mechanisms without a definitive human trial behind them. Sunscreen is not one of them. This is one of the rare cases in skincare with an actual long-term, randomized controlled trial behind it — and the result is specific enough to be genuinely useful, not just a vague “protect your skin” gesture.
The trial that settled this
Between 1992 and 1996, researchers in Nambour, Australia — a subtropical region with some of the highest skin cancer rates in the world — ran a randomized controlled trial that is still the gold-standard evidence on this question. Over 900 adults under 55 were randomly assigned to either daily sunscreen application or “discretionary” use, meaning they applied it only when they personally felt they needed to, which in practice meant far less consistent use. They were followed for 4.5 years. The daily-use group showed a 24% reduction in visible skin ageing compared with the discretionary group — a measurable difference from one variable alone, in a trial designed specifically to isolate that variable rather than infer it from observational data. The same trial’s longer follow-up also found daily use reduced the rate of precancerous solar keratoses.
This matters because most of what is claimed about skincare ingredients comes from smaller, shorter, or observational studies, where it is hard to separate cause from coincidence — people who use sunscreen diligently also tend to have other sun-cautious habits. A randomized trial removes that ambiguity: the only difference between the two groups was assigned, not chosen, which is why this particular piece of evidence carries more weight than most things you will read about skincare.
Why “just summer” misunderstands the actual exposure
The instinct to treat sunscreen as a summer or beach-day product comes from conflating it with sunburn prevention, which is mostly a UVB story — UVB intensity does genuinely vary with season and is what causes the burning you notice. But photoaging is driven substantially by UVA radiation, and UVA behaves very differently: it is present at meaningfully similar intensity across seasons and, critically, throughout the entire day rather than concentrated around midday peaks. UVA also penetrates deeper into the skin, reaching the dermis where collagen and elastin live — the structural proteins whose breakdown is what actually produces visible ageing, fine lines, and loss of elasticity, as opposed to the surface redness of a burn.
There is a specific, easy-to-overlook detail here worth knowing: UVA passes through window glass, while UVB largely does not. That means the side of your face nearer a window during a commute, an office day, or time in a car accumulates UVA exposure you would never notice as a burn — a slow, invisible source of cumulative damage that has nothing to do with how sunny it looks outside or what season it is.
UVA’s slow, cumulative structural damage does not pause for cloud cover or January.
— WellnessLife editorial
The honest complication worth knowing
There is a genuine nuance the marketing rarely mentions: some research has found that people using sunscreen sometimes extend the length of time they spend in the sun, particularly with higher-SPF products, partly offsetting the benefit by increasing overall exposure time even as burn risk per hour goes down. This is not a reason to skip sunscreen — the Nambour trial’s 24% reduction already reflects real-world use, behavioural effects included — but it is a reason not to treat sunscreen as a licence for extended sun exposure. Reapplication, shade during peak hours, and sunscreen working together is still more defensible than treating sunscreen as a standalone shield.
- Daily sunscreen use cut visible skin ageing by 24% over 4.5 years in a randomized controlled trial — the strongest evidence in skincare for any single step
- The same trial also found reduced rates of precancerous solar keratoses with daily use
- Sunburn is largely UVB; photoaging is largely UVA, and the two behave differently by season and time of day
- UVA reaches the dermis, where the collagen and elastin breakdown behind lines and lost elasticity happens
- UVA passes through window glass; UVB largely does not — indoor and in-car exposure is real and unnoticed
- Higher SPF can lead people to stay out longer, partly offsetting the protection — sunscreen is not a licence for unlimited exposure
- The evidenced approach is broad-spectrum SPF 30 or higher, daily, regardless of season or weather
The practical takeaway
The evidence supports daily application of broad-spectrum sunscreen — meaning it covers both UVA and UVB — regardless of season, weather, or whether you are spending the day mostly indoors near windows. Not because every day carries burn risk, but because UVA’s cumulative structural damage does not pause for cloud cover. SPF 30 or higher, reapplied if you are outdoors for extended periods, remains the most well-evidenced single anti-ageing intervention in skincare, better supported by controlled trial data than most of what gets marketed far more aggressively.
Sources
- Hughes MC, Williams GM, Baker P, Green AC. “Sunscreen and prevention of skin aging: a randomized trial.” Annals of Internal Medicine, 2013 — the Nambour Skin Cancer and Actinic Eye Disease Prevention Trial.
- Green AC, et al. “The Nambour Skin Cancer and Actinic Eye Disease Prevention Trial: design and baseline characteristics of participants.”
- Autier P, et al. Research on sunscreen use and behavioural changes in sun exposure duration.
- Research on UVA1 exposure patterns, seasonal consistency, and window-glass penetration versus UVB.
